The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling

The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling

Summary: Background: COVID-19 is characterized by a heterogeneous clinical presentation, ranging from mild symptoms to severe courses of disease. 9–20% of hospitalized patients with severe lung disease die from COVID-19 and a substantial number of survivors develop long-COVID. Our objective was to...

Full description

Bibliographic Details
Main Authors: Maximilian Ackermann, Jan C. Kamp, Christopher Werlein, Claire L. Walsh, Helge Stark, Verena Prade, Rambabu Surabattula, Willi L. Wagner, Catherine Disney, Andrew J. Bodey, Thomas Illig, Diana J. Leeming, Morten A. Karsdal, Alexandar Tzankov, Peter Boor, Mark P. Kühnel, Florian P. Länger, Stijn E. Verleden, Hans M. Kvasnicka, Hans H. Kreipe, Axel Haverich, Stephen M. Black, Axel Walch, Paul Tafforeau, Peter D. Lee, Marius M. Hoeper, Tobias Welte, Benjamin Seeliger, Sascha David, Detlef Schuppan, Steven J. Mentzer, Danny D. Jonigk
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:EBioMedicine
Subjects:
COVID-19
Intussusceptive angiogenesis
Fibrogenesis
Biomarkers
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396422004789

Internet

http://www.sciencedirect.com/science/article/pii/S2352396422004789

Similar Items